Cargando…

171. Impact of Limiting Antimicrobial Indication Options in a Pediatric Electronic Health Record

BACKGROUND: In April 2005, our Antimicrobial Stewardship Program (ASP) started to require prescribers to select an indication as part of an antimicrobial (AM) order. The ASP developed a list of approved indications for each AM with an unlimited number of options including “other.” In 2015–2016, we m...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapiro, Craig, Chan, Shannon, Ravin, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253659/
http://dx.doi.org/10.1093/ofid/ofy210.184
_version_ 1783373547560763392
author Shapiro, Craig
Chan, Shannon
Ravin, Karen
author_facet Shapiro, Craig
Chan, Shannon
Ravin, Karen
author_sort Shapiro, Craig
collection PubMed
description BACKGROUND: In April 2005, our Antimicrobial Stewardship Program (ASP) started to require prescribers to select an indication as part of an antimicrobial (AM) order. The ASP developed a list of approved indications for each AM with an unlimited number of options including “other.” In 2015–2016, we modified the indication lists to decrease the number of options. The goal of this project is to compare the frequency of indication “other” and the appropriateness of provider-selected indications before and after the intervention. METHODS: We performed a retrospective cohort study of cefepime, ceftriaxone, piperacillin/tazobactam, and ciprofloxacin (IV) orders for all children in our facility excluding orders placed in ambulatory locations and the emergency department. AM orders and provider-selected indications from January to March 2014 (preintervention) and 2017 (postintervention) were compared. Chart review was performed on a sample of pre- and postmodification orders to assess the appropriateness of provider-selected indications. An indication was considered appropriate if the provider-selected indication matched the clinical indication documented. RESULTS: A total of 747 orders were included in the data analysis, 350 and 397 orders from pre- and postintervention period, respectively. Ceftriaxone was the most commonly prescribed AM:13.7 and 17.2 orders per 1,000 inpatients-days during pre- and postintervention periods. The percent of indication “other” orders increased in the postintervention period for ceftriaxone while it decreased for ciprofloxacin and remained about the same for cefepime and piperacillin/tazobactam. Most prescribers who selected indication “other” for ceftriaxone during the postintervention period did not provide a reason (29.8%). The agreement between clinical and provider-selected indications was consistent in pre- and postintervention period except piperacillin/tazobactam (RR = 0.56). CONCLUSION: Requiring selection of an indication encourages prescribers to evaluate their rationale for initiating an AM. Decreasing the number of indication options for some AMs was associated with increased use of indication “other,” suggesting that the prescriber could not find an indication that matched their needs. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6253659
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62536592018-11-28 171. Impact of Limiting Antimicrobial Indication Options in a Pediatric Electronic Health Record Shapiro, Craig Chan, Shannon Ravin, Karen Open Forum Infect Dis Abstracts BACKGROUND: In April 2005, our Antimicrobial Stewardship Program (ASP) started to require prescribers to select an indication as part of an antimicrobial (AM) order. The ASP developed a list of approved indications for each AM with an unlimited number of options including “other.” In 2015–2016, we modified the indication lists to decrease the number of options. The goal of this project is to compare the frequency of indication “other” and the appropriateness of provider-selected indications before and after the intervention. METHODS: We performed a retrospective cohort study of cefepime, ceftriaxone, piperacillin/tazobactam, and ciprofloxacin (IV) orders for all children in our facility excluding orders placed in ambulatory locations and the emergency department. AM orders and provider-selected indications from January to March 2014 (preintervention) and 2017 (postintervention) were compared. Chart review was performed on a sample of pre- and postmodification orders to assess the appropriateness of provider-selected indications. An indication was considered appropriate if the provider-selected indication matched the clinical indication documented. RESULTS: A total of 747 orders were included in the data analysis, 350 and 397 orders from pre- and postintervention period, respectively. Ceftriaxone was the most commonly prescribed AM:13.7 and 17.2 orders per 1,000 inpatients-days during pre- and postintervention periods. The percent of indication “other” orders increased in the postintervention period for ceftriaxone while it decreased for ciprofloxacin and remained about the same for cefepime and piperacillin/tazobactam. Most prescribers who selected indication “other” for ceftriaxone during the postintervention period did not provide a reason (29.8%). The agreement between clinical and provider-selected indications was consistent in pre- and postintervention period except piperacillin/tazobactam (RR = 0.56). CONCLUSION: Requiring selection of an indication encourages prescribers to evaluate their rationale for initiating an AM. Decreasing the number of indication options for some AMs was associated with increased use of indication “other,” suggesting that the prescriber could not find an indication that matched their needs. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253659/ http://dx.doi.org/10.1093/ofid/ofy210.184 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Shapiro, Craig
Chan, Shannon
Ravin, Karen
171. Impact of Limiting Antimicrobial Indication Options in a Pediatric Electronic Health Record
title 171. Impact of Limiting Antimicrobial Indication Options in a Pediatric Electronic Health Record
title_full 171. Impact of Limiting Antimicrobial Indication Options in a Pediatric Electronic Health Record
title_fullStr 171. Impact of Limiting Antimicrobial Indication Options in a Pediatric Electronic Health Record
title_full_unstemmed 171. Impact of Limiting Antimicrobial Indication Options in a Pediatric Electronic Health Record
title_short 171. Impact of Limiting Antimicrobial Indication Options in a Pediatric Electronic Health Record
title_sort 171. impact of limiting antimicrobial indication options in a pediatric electronic health record
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253659/
http://dx.doi.org/10.1093/ofid/ofy210.184
work_keys_str_mv AT shapirocraig 171impactoflimitingantimicrobialindicationoptionsinapediatricelectronichealthrecord
AT chanshannon 171impactoflimitingantimicrobialindicationoptionsinapediatricelectronichealthrecord
AT ravinkaren 171impactoflimitingantimicrobialindicationoptionsinapediatricelectronichealthrecord